Active Pharmaceutical Ingredient Manufacturing Grant Fund; established.
Introduced
Moved
Reached a final decision
Became law
Derived from the official record below.
Officially: “An Act to amend the Code of Virginia by adding in Title 59.1 a chapter numbered 22.25, consisting of a section numbered 59.1-284.46, relating to Active Pharmaceutical Ingredient Manufacturing Grant Fund.” Read the full text
2026 session
What it does
Active Pharmaceutical Ingredient Manufacturing Grant Fund. Establishes the Active Pharmaceutical Ingredient Manufacturing Grant Fund to provide grant installment awards between July 1, 2026, and July 1, 2045, in an amount not to exceed $15 million per fiscal year and in an aggregate amount not to exceed $130 million, to a qualified company that (i) engages in the manufacture of pharmaceutical substances, (ii) executes a memorandum of understanding with the Commonwealth, and (iii) is expected to
From the official legislative record, shown verbatim. Not legal advice.
Where it is
Introduced · Jan 13, 2026
Acts of Assembly Chapter 822 (latest official status)
Latest official status shown, exactly as the official record states it. The step by step history lives on the official page linked below.
The numbers
1
sponsor on the bill
Sponsors
L. Louise Lucas
Recorded votes
Passed House (97-Y 0-N 0-A)House of Delegates · 2026-02-25 · P · Y 97, X 2
Reported from Appropriations (22-Y 0-N)House of Delegates · 2026-02-20 · P · Y 22
Read third time and passed Senate (38-Y 0-N 0-A)Senate · 2026-01-30 · P · Y 38, X 2
Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A)Senate · 2026-01-28 · P · Y 40
Reported from Finance and Appropriations (14-Y 0-N)Senate · 2026-01-27 · P · Y 14, X 1
Roll-call results shown verbatim from the Virginia legislature’s records. A result reflects that roll call’s own motion, not the bill’s overall outcome.
Every fact on this page links to its source, starting with the official bill record. Last action: Acts of Assembly Chapter 822.